ArticleCancer immunology, immunotherapy : CII2014

A phase I clinical trial combining dendritic cell vaccination with adoptive T cell transfer in patients with stage IV melanoma.

Isabel Poschke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.